Concepedia

Gili Hart

GH

15

Publications

474

Citations

14

H-Index

1979

Active since

Affiliations

Weizmann Institute of Science(Current)

Tel Aviv Sourasky Medical Center

Tel Aviv University

Intel (Israel)

Oregon Health & Science University

Gili Hart is an author at Weizmann Institute of Science specializing in medicine, immunology, and cell signaling.

ORCID

Top concepts

Publications per year

1979–2023

15

Publications

15

Long-Acting C-Terminal Peptide–Modified hGH (MOD-4023): Results of a Safety and Dose-Finding Study in GHD Children

Nataliya Zelinska, Violeta Iotova, Julia Skorodok et al. · The Journal of Clinical Endocrinology & Metabolism · 2017 · 69 citations · Full text

Expression of the chemokine receptor CCR2 on immature B cells negatively regulates their cytoskeletal rearrangement and migration

Liat Flaishon, Shirly Becker-Herman, Gili Hart et al. · Blood · 2004 · 46 citations · Full text

MOD-4023, a long-acting carboxy-terminal peptide-modified human growth hormone: results of a Phase 2 study in growth hormone-deficient adults

Christian J. Strasburger, Peter Vaňuga, Juraj Payer et al. · European Journal of Endocrinology · 2016 · 46 citations · Full text

<i>In Vitro</i> and <i>in Vivo</i> Characterization of MOD-4023, a Long-Acting Carboxy-Terminal Peptide (CTP)-Modified Human Growth Hormone

Oren Hershkovitz, Ahuva Bar-Ilan, Rachel Guy et al. · Molecular Pharmaceutics · 2015 · 44 citations

, , +18

Pharmacokinetic and Pharmacodynamic Modeling of MOD-4023, a Long-Acting Human Growth Hormone, in Growth Hormone Deficiency Children

Dennis M. Fisher, Ron G. Rosenfeld, Michal Jaron‐Mendelson et al. · Hormone Research in Paediatrics · 2017 · 42 citations · Full text

Rows per page

1–5 of 15